Nirsevimab Reduced Hospitalizations Among Infants With RSV-Associated Lower Respiratory Tract Infection, Randomized Trial Finds
December 28, 2023
MedPage Today (12/27, Kahn) reports, “The monoclonal antibody nirsevimab reduced hospitalizations among infants with respiratory syncytial virus (RSV)-associated lower respiratory tract infection, the randomized, pragmatic HARMONIE trial showed.” The findings were published in the New England Journal of Medicine.